Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Baxter
Moodys
McKinsey
Johnson and Johnson

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

PROLEUKIN Drug Profile

See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for PROLEUKIN

Identify potential brand extensions & biosimilar entrants

SponsorPhase
University of California, San FranciscoPhase 1/Phase 2
University of FloridaPhase 1/Phase 2
Diabetes Research Institute FoundationPhase 1/Phase 2

See all PROLEUKIN clinical trials

Recent Litigation for PROLEUKIN

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Amgen Inc. v. Accord Healthcare, Inc.2018-06-28

See all PROLEUKIN litigation

Pharmacology for PROLEUKIN

Patent Text Search: US Patents for PROLEUKIN

These patents were identified by searching patent claims

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
McKinsey
Colorcon
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.